Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News COMPASS Pathways Plc CMPS

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant...

The Power Play by The Market Herald
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:CMPS)

Fundamentals Snapshot (NDAQ:CMPS)

Opinion & Analysis (NDAQ:CMPS)

No current opinion is available.

Bullboard Posts (NDAQ:CMPS)

Buy for me here, stock seems cheap.

Stage 3 trials
FukDaFed - February 22, 2022

The declining sp is affecting my mental health

This stock is not getting very much love. 
MushLove - December 12, 2021

Compass Pathways Granted Its Tenth Overall Patent Related To

Compass Pathways this morning issued a brief release, indicating it has been granted a fifth patent in the United States. The patent is...
AwareInvestor - November 23, 2021

Compass Pathways Closes Enrollment For Phase IIb Psilocybin

Compass Pathways this morning provided a brief update to the market on the latest status of its ongoing phase IIb psilocybin therapy...
AwareInvestor - June 28, 2021


Entering Brazil , Oregon Rec Markets , Netherlands!!
KandiBirdBoy - April 30, 2021

David Nutt: Amanita Muscaria Due For More Research – The Dai

Today host Cassandra Leah sits down with Dr David Nutt, a highly experienced neuropsychopharmacologist, the chair of the scientific...
AwareInvestor - March 10, 2021